SCHEMBL17862271

SCHEMBL17862271

CCCn1c(-c2ccc(-c3cc4c(c5ccccc35)-c3c(c5ccccc5c5ccccc35)C4(C)C)cc2)nc2ccccc21

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.53
KDM4E B2RXH2 8/20 0.51
ALDH1A1 P00352 6/20 0.51
LMNA P02545 2/20 0.51
TSHR P16473 2/20 0.51
GAA P10253 2/20 0.51
NPSR1 Q6W5P4 2/20 0.51
TP53 P04637 3/20 0.45
CYP11B1 P15538 1/20 0.43
HPGD P15428 4/20 0.42
HSD17B10 Q99714 2/20 0.42
SMN1; SMN2 Q16637 3/20 0.41
PTGER4 P35408 1/20 0.41
HTT P42858 2/20 0.40
MEN1 O00255 1/20 0.40
NPC1 O15118 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17862340 0.93 MAPT (0.57) MAPTKDM4EALDH1A1LMNATSHR
SCHEMBL17862336 0.92 KDM4E (0.51) MAPTKDM4EALDH1A1LMNATSHR
SCHEMBL17862980 0.89 KDM4E (0.52) MAPTKDM4EALDH1A1LMNATSHR
SCHEMBL20736847 0.87 MAPT (0.50) MAPTKDM4EALDH1A1LMNATSHR
SCHEMBL17862267 0.86 ALDH1A1 (0.48) MAPTKDM4EALDH1A1LMNAGAA
SCHEMBL17862287 0.85 MAPT (0.46) MAPTKDM4EALDH1A1LMNATSHR
SCHEMBL17862599 0.84 KDM4E (0.49) MAPTKDM4EALDH1A1LMNATSHR
SCHEMBL17863006 0.82 MAPT (0.55) MAPTKDM4EALDH1A1LMNATSHR
SCHEMBL17862270 0.82 ESR1 (0.44) MAPTALDH1A1LMNAGAAPTGER4
SCHEMBL20737703 0.82 KDM4E (0.48) MAPTKDM4EALDH1A1LMNATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10396288-B2 Organic electroluminescent element and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2019-08-27 US disclosed
US-20160181543-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2016-06-23 US disclosed
US-20160181543-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2016-06-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10396288-B2 Organic electroluminescent element and electronic device RER1, LEF1, ELP1 MAPT 4453/4885KDM4E 3266/4885ALDH1A1 787/4885
US-20160181543-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE RER1, LEF1, RPL18 MAPT 4458/4885KDM4E 3259/4885ALDH1A1 804/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.